BRCA1 and neoplasm: Reduced BRCA1 protein levels might result in insufficient or loss of BRCA1 function that contribute to BRCA1 deficiency and tumors with reduced protein levels of BRCA1 may share molecular features of BRCA1-mutant tumor and respond to PARPi therapy.